Laura Brege

Director · 4 filings · Latest: Jun 15, 2026

ACADIA PHARMACEUTICALS INC

Edgewise Therapeutics, Inc.

Mirum Pharmaceuticals, Inc.

Pacira BioSciences, Inc.

Ticker	Owner	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Filing
ACAD	Laura Brege	Director	May 29, 2026	Option Exercise	—	8,107	—	23,202	Jun 1 10:00 PM
MIRM	LAURA BREGE	—	Sep 11, 2025	Proposed Sale	$74.41	17,000	$1.3M	—	Sep 11 8:04 PM
ACAD	LAURA BREGE	—	Jun 4, 2025	Proposed Sale	$21.78	14,446	$314.6K	—	Jun 4 8:35 PM